Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-10 10:09 am Sale | 2022-12-31 | 13G | Silk Road Medical, Inc SILK | Deerfield Mgmt, L.P. | 1,396,640 3.660% | -465,277![]() (-24.99%) | Filing History |
2023-02-10 10:08 am Sale | 2022-12-31 | 13G | Profound Medical Corp. PROF | Deerfield Mgmt, L.P. | 0 0.000% | -1,713,797![]() (Position Closed) | Filing History |
2023-02-10 10:07 am Sale | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | Deerfield Mgmt, L.P. | 316,171 2.500% | -378,771![]() (-54.50%) | Filing History |
2023-02-10 10:06 am Sale | 2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Deerfield Mgmt, L.P. | 0 0.000% | -8,456,876![]() (Position Closed) | Filing History |
2023-02-10 10:05 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | Deerfield Mgmt, L.P. | 2,383,000 3.560% | -1,130,756![]() (-32.18%) | Filing History |
2023-02-10 10:03 am Sale | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deerfield Mgmt, L.P. | 0 0.000% | -2,344,786![]() (Position Closed) | Filing History |
2023-02-10 10:01 am Unchanged | 2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Deerfield Mgmt, L.P. | 3,933,137 6.220% | 0 (Unchanged) | Filing History |
2023-02-10 10:00 am Sale | 2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI | Deerfield Mgmt, L.P. | 0 0.000% | -4,695,020![]() (Position Closed) | Filing History |
2023-02-10 09:58 am Unchanged | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Deerfield Mgmt, L.P. | 1,739,130 5.060% | 0 (Unchanged) | Filing History |
2023-02-10 09:45 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Deerfield Mgmt, L.P. | 3,424,852 2.520% | -3,176,148![]() (-48.12%) | Filing History |
2023-02-10 09:44 am Sale | 2022-12-31 | 13G | ImmunoGen, Inc. IMGN | Deerfield Mgmt, L.P. | 6,358,314 2.880% | -8,421,276![]() (-56.98%) | Filing History |
2023-02-10 09:43 am Unchanged | 2022-12-31 | 13G | Eucrates Biomedical Acquisition Corp. EUCR | Deerfield Mgmt, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2023-02-10 09:42 am Sale | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 2,349,228 3.480% | -3,231,228![]() (-57.90%) | Filing History |
2023-02-10 09:40 am Sale | 2022-12-31 | 13G | Cogent Biosciences, Inc. COGT | Deerfield Mgmt, L.P. | 2,966,345 4.240% | -2,910,460![]() (-49.52%) | Filing History |
2023-02-10 09:39 am Sale | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | Deerfield Mgmt, L.P. | 1,161,826 4.090% | -304,774![]() (-20.78%) | Filing History |
2023-02-10 09:37 am Sale | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Deerfield Mgmt, L.P. | 2,052,010 5.770% | -2,784![]() (-0.14%) | Filing History |
2023-02-10 09:36 am Sale | 2022-12-31 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 2,380,438 5.140% | -141,115![]() (-5.60%) | Filing History |
2023-02-10 09:34 am Unchanged | 2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Deerfield Mgmt, L.P. | 2,032,335 5.510% | 0 (Unchanged) | Filing History |
2023-02-10 09:33 am Purchase | 2022-12-31 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 2,694,101 8.080% | 76,153![]() (+2.91%) | Filing History |
2023-02-10 09:32 am Purchase | 2022-12-31 | 13G | Evolus, Inc. EOLS | Deerfield Mgmt, L.P. | 3,319,000 5.900% | 288,701![]() (+9.53%) | Filing History |